Second malignant neoplasms after treatment of childhood cancer

By Klein G.   Michaelis J.   Spix C.   Wibbing R.   Eggers G.   Ritter J.   Kaatsch P.  

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 808-817

Elsevier

Access to resources Recommend Favorite

Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma

By Xu Yuanlin  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1396-1404

Informa Healthcare

Access to resources Recommend Favorite

Second primary neoplasms after 19281 endocrine gland tumours - aetiological links?

By Hemminki K.   Jiang Y.  

European Journal of Cancer, Vol. 37, Iss. 15, 2001-10 ,pp. : 1886-1894

Elsevier

Access to resources Recommend Favorite

Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study

By D’Angelica Michael   Kornprat Peter   Gonen Mithat   Chung Ki-Young   Jarnagin William   DeMatteo Ronald   Fong Yuman   Kemeny Nancy   Blumgart Leslie   Saltz Leonard B  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 759-765

Springer Publishing Company

Access to resources Recommend Favorite

Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy

By Yang Sen   Yan Hong-Li   Tao Qi-Fei   Yuan Sheng-Xian   Tang Guan-Nan   Yang Yuan   Wang Li-Li   Zhang Yi-Liang   Sun Shu-Han   Zhou Wei-Ping  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 109-116

Springer Publishing Company

Access to resources Recommend Favorite